Xerostomia Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2032, estimates DelveInsight | Camurus AB, Saliwell Ltd., RiboX Therapeutics Ltd., TorreyPines Therapeutics, Otsuka Pharmaceutical Co., Ltd., Acacia Pharma Ltd, MeiraGTx LLC,

DelveInsight's "Xerostomia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Xerostomia, historical and forecasted epidemiology as well as the Xerostomia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Discover which therapies are expected to grab the Xerostomia Market Share @ Xerostomia Market Outlook- https://www.delveinsight.com/sample-request/xerostomia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Xerostomia Market Report
• In March 2025, RiboX Therapeutics Ltd announced a first-in-human clinical study to evaluate the safety, tolerability and efficacy of RXRG001 administered in the ducts of the parotid glands in adult patients with radiation-induced xerostomia (dry mouth) and hyposalivation (reduced saliva production).
• In March 2025, Novartis Pharmaceuticals organized a study aims at elucidating the mechanism of action of ianalumab in salivary glands and explore relationships with clinical assessments.
• In March 2025, argenx announced a study is to evaluate the efficacy of efgartigimod PH20 SC in patients with moderate-to-severe Primary Sjögren's Disease (pSjD). The study consists of a double-blinded placebo-controlled treatment period and an open-label treatment period. The maximum study duration for participants in both study parts is approximately 105 weeks.
• The increase in Xerostomia Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
• As per DelveInsight analysis, the Xerostomia Market is anticipated to witness growth at a considerable CAGR.
• The leading Xerostomia Companies such Camurus AB, Saliwell Ltd., RiboX Therapeutics Ltd., TorreyPines Therapeutics, Otsuka Pharmaceutical Co., Ltd., Acacia Pharma Ltd, MeiraGTx LLC, Bristol-Myers Squibb, Novartis Pharmaceuticals and others.
• Promising Xerostomia Pipeline Therapies such as XER2020, RXRG001, NGX267, P-552, Rebamipide, APD515 and others.

Stay ahead in the Xerostomia Therapeutics Market with DelveInsight's Strategic Report @ Xerostomia Market Outlook- https://www.delveinsight.com/sample-request/xerostomia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Xerostomia Epidemiology Segmentation in the 7MM
The epidemiology section of Xerostomia offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.

Download the report to understand which factors are driving Xerostomia Epidemiology trends @ Xerostomia Prevalence- https://www.delveinsight.com/sample-request/xerostomia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Xerostomia Drugs Market
The Xerostomia Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Xerostomia signaling in Xerostomia are likely to uncover new therapeutic targets and further expand treatment options for patients.

Xerostomia Treatment Market Landscape
The Xerostomia treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Xerostomia has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.

To learn more about Xerostomia treatment guidelines, visit @ Xerostomia Treatment Market Landscape- https://www.delveinsight.com/sample-request/xerostomia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Xerostomia Market Outlook
The report's outlook on the Xerostomia market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Xerostomia therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Xerostomia drug and late-stage pipeline therapy.

Xerostomia Drugs Uptake
The drug chapter of the Xerostomia report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Xerostomia.

Major Xerostomia Companies
Camurus AB, Saliwell Ltd., RiboX Therapeutics Ltd., TorreyPines Therapeutics, Otsuka Pharmaceutical Co., Ltd., Acacia Pharma Ltd, MeiraGTx LLC, Bristol-Myers Squibb, Novartis Pharmaceuticals and others.

Learn more about the FDA-approved drugs for Xerostomia @ Drugs for Xerostomia Treatment- https://www.delveinsight.com/sample-request/xerostomia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Xerostomia Market Report
• Coverage- 7MM
• Study Period- 2019-2032
• Xerostomia Companies- Camurus AB, Saliwell Ltd., RiboX Therapeutics Ltd., TorreyPines Therapeutics, Otsuka Pharmaceutical Co., Ltd., Acacia Pharma Ltd, MeiraGTx LLC, Bristol-Myers Squibb, Novartis Pharmaceuticals and others.
Xerostomia Pipeline Therapies- XER2020, RXRG001, NGX267, P-552, Rebamipide, APD515 and others.
• Xerostomia Market Dynamics: Xerostomia Market Drivers and Barriers
• Xerostomia Market Access and Reimbursement, Unmet Needs and Future Perspectives

Discover more about Xerostomia Drugs in development @ Xerostomia Clinical Trials Assessment- https://www.delveinsight.com/sample-request/xerostomia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Key Insights
2. Xerostomia Executive Summary
3. Competitive Intelligence Analysis for Xerostomia
4. Xerostomia: Market Overview at a Glance
5. Xerostomia: Disease Background and Overview
6. Patient Journey
7. Xerostomia Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Xerostomia Unmet Needs
10. Key Endpoints of Xerostomia Treatment
11. Xerostomia Marketed Products
12. Xerostomia Emerging Therapies
13. Xerostomia: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Xerostomia Market Outlook
16. Access and Reimbursement Overview of Xerostomia
17. KOL Views
18. Xerostomia Market Drivers
19. Xerostomia Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight

List of Top Selling Market Research Reports in 2025

Biopsy devices market- https://www.delveinsight.com/report-store/biopsy-devices-market
Diabetic wound market - https://www.delveinsight.com/report-store/diabetic-wounds-market
Joint reconstruction devices market- https://www.delveinsight.com/report-store/joint-reconstruction-devices-market
Pipeline assessment services- https://www.delveinsight.com/consulting/pipeline-assessment-services
Spinal implants market- https://www.delveinsight.com/report-store/spinal-implants-market
Attention deficit hyperactivity disorder market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Cystic fibrosis market- https://www.delveinsight.com/report-store/cystic-fibrosis-market
Heart failure market- https://www.delveinsight.com/report-store/congestive-heart-failure-market
NK Cell therapy market- https://www.delveinsight.com/report-store/nk-cell-therapy-market
Positive airway pressure device market - https://www.delveinsight.com/report-store/positive-airway-pressure-device-market
Stem cell market- https://www.delveinsight.com/report-store/stem-cell-market
Surgical sealant market- https://www.delveinsight.com/report-store/surgical-sealant-tissue-patch-market
Thyroid cancer market- https://www.delveinsight.com/report-store/thyroid-cancer-market
Urinary catheters market- https://www.delveinsight.com/report-store/urinary-catheters-market
Intraocular lens market- https://www.delveinsight.com/blog/top-companies-in-the-intraocular-lens-market
Uterine fibroids market- https://www.delveinsight.com/report-store/uterine-leiomyoma-uterine-fibroids-market
Attention deficit hyperactivity disorder adhd market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Lice infestations market- https://www.delveinsight.com/report-store/lice-infestations-market
Lymphoedema market- https://www.delveinsight.com/report-store/lymphoedema-market
Dyspepsia market- https://www.delveinsight.com/report-store/functional-dyspepsia-pipeline-insight
Antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Surgical mask & respirator market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market
Bone growth stimulator market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Contact Us
Yash Bhardwaj
info@delveinsight.com
https://www.delveinsight.com/

This release was published on openPR.